SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-008297
Filing Date
2024-03-18
Accepted
2024-03-18 17:19:01
Documents
2
Period of Report
2024-03-14

Document Format Files

Seq Description Document Type Size
1 form3-03182024_090343.html 3  
1 form3-03182024_090343.xml 3 1774
2 ex24-03182024_090343.htm EX-24 7538
  Complete submission text file 0001415889-24-008297.txt   10809
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005
Business Address
Chong Ngai Hang Victor (Reporting) CIK: 0002014921 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37783 | Film No.: 24760115